Swiss-GO is here for you and your patient!
For evaluation and support for your research projects in the field of gynecological oncology and the coordination and implementation of your studies.
In Switzerland, every year, approximately 800 women are diagnosed with ovarian, fallopian tube or peritoneal cancer. (Filler800 women are diagnosed with ovarian, fallopian tube or peritoneal)
MATAO - A clinical phase III trial on the use of letrozole maintenance therapy for newly diagnosed advanced ovarian, fallopian tube or peritoneal cancers. (varian, fallopian tube or peritoneal cancers)
The IRMA Study is a multicenter observational cohort study of women undergoing immediate breast reconstruction following either prophylactic mastectomy or mastectomy due to breast cancer.
BOUQUET Trial: Rare Ovarian cancers
This study will evaluate the efficacy and safety of multiple biomarker-selected treatments in patients with persistent or recurrent rare epithelial ovarian, fallopian tube, or primary peritoneal tumors